Table 1.
Descriptives of invitees of the prevalence, risk factors and impact evaluation of post-COVID-19 condition (PRIME post-COVID) study.
| Test result, n (%) | Invitees n = 61,655 | |
|---|---|---|
| Negative | Positive | |
| 19,875 (32.2) | 41,780 (67.8) | |
| Sex, n(%) | ||
| Men | 9,917 (49.9) | 18,794 (45.0) |
| Women | 9,958 (50.1) | 22,986 (55.0) |
| Age, n(%) | ||
| 18–20 years | 1,211 (6.1) | 3,519 (8.4) |
| 20–30 years | 3,719 (18.7) | 9,367 (22.4) |
| 30–40 years | 3,202 (16.1) | 6,823 (16.3) |
| 40–50 years | 2,991 (15.1) | 6,560 (15.7) |
| 50–60 years | 3,678 (18.5) | 7,816 (18.7) |
| 60–70 years | 3,098 (15.6) | 4,697 (11.2) |
| 70–80 years | 1,525 (7.7) | 2,252 (5.4) |
| 80+ years | 451 (2.3) | 746 (1.8) |
| Year-quarter of test, n(%) | ||
| 2nd 2020* | 361 (1.8) | 49 (0.1) |
| 3rd 2020 | 2,267 (11.4) | 716 (1.7) |
| 4th 2020 | 5,718 (28.8) | 12,060 (28.9) |
| 1st 2021 | 4,255 (21.4) | 9,341 (22.4) |
| 2nd 2021 | 3,635 (18.3) | 9,561 (22.9) |
| 3rd 2021 | 2,483 (12.5) | 6,106 (14.6) |
| 4th 2021** | 1,156 (5.8) | 3,947 (9.4) |
*From June 2020.
**Until November 2021.